Status:
COMPLETED
Effect of Continuous Glucose Monitoring on Course of Glucose in Type 1 Diabetes
Lead Sponsor:
Forschungsinstitut der Diabetes Akademie Mergentheim
Conditions:
Type 1 Diabetes
Hypoglycemia
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The objective of this cross over study is to access if continuous glucose monitoring (CGMS) with a real time feed back and hypoglycemic as well as hyperglycemic glucose alerts vs. only retrospective a...
Detailed Description
The objective of this cross over study is to access if continuous glucose monitoring (CGMS) with a real time feed back and hypoglycemic as well as hyperglycemic glucose alerts vs. only retrospective a...
Eligibility Criteria
Inclusion
- type 1 diabetes
- Age \> 18 years
- Informed consent
Exclusion
- Diagnosis and/or treatment of a current psychiatric disease
- Severe late complications
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00467688
Start Date
February 1 2007
End Date
July 1 2007
Last Update
October 31 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
FIDAM
Bad Mergentheim, Germany, D-97980
2
Research Institute of the Diabetes Academy Mergentheim
Bad Mergentheim, Germany, D-97980